Literature DB >> 23405291

Genome Sequence of the Human Abscess Isolate Streptococcus intermedius BA1.

Paul J Planet1, Ryan Rampersaud, Saul R Hymes, Susan Whittier, Phyllis A Della-Latta, Apurva Narechania, Sean C Daugherty, Ivette Santana-Cruz, Robert Desalle, Jacques Ravel, Adam J Ratner.   

Abstract

Streptococcus intermedius is a human pathogen with a propensity for abscess formation. We report a high-quality draft genome sequence of S. intermedius strain BA1, an isolate from a human epidural abscess. This sequence provides insight into the biology of S. intermedius and will aid investigations of pathogenicity.

Entities:  

Year:  2013        PMID: 23405291      PMCID: PMC3569275          DOI: 10.1128/genomeA.00117-12

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Streptococcus intermedius is a member of the anginosus or Streptococcus milleri group (SMG), which also includes S. constellatus and S. anginosus (1). This organism is part of the normal microbiota of human mucosal surfaces, including the upper respiratory and lower genital tracts, and can cause liver and brain abscesses, bacteremia, osteoarticular infections, and endocarditis (2–5). SMG bacteria are also newly recognized as likely pathogens in cystic fibrosis pulmonary infections (6). The strain BA1 was isolated from an intracranial abscess in a child who presented with complicated mastoiditis and osteomyelitis of the skull. The identification of the organism was confirmed by PCR and sequencing of the 16S rRNA genes and the gene encoding intermedilysin (ILY) (7). The whole genome sequence of S. intermedius BA1 was determined using a hybrid approach including Roche/454 GS-FLX sequencing (593,795 reads; 378-bp average read length) and Pacific Biosciences (PacBio) R.S. sequencing (319,206 reads; 1,122-bp average read length). The sequencing errors of single-molecule reads were corrected by mapping 454 reads onto longer PacBio R.S. reads using an algorithm previously described (8). The resulting 24,599 corrected PacBio R.S. reads larger than 2,000 bp were assembled using Newbler (version 2.7) and yielded 49 contigs with a total size of 1,966,076 bp (N50, 209,077 bp) and 30-fold genome coverage. Fourteen long (>10-kbp) contigs contained 1,896,811 bp in total (96.5% of the genome sequence). Annotation was performed using the IGS prokaryotic annotation engine (9). The genome sequence has a G+C content of 37.8%, 63 tRNA genes, 6 rRNA genes, and 2,028 predicted coding sequences (with an average gene length of 848 nucleotides [nt]) comprising 87% of the genome. The complement of putative virulence factors identified in the annotated draft genome sequence of S. intermedius BA1 has considerable similarity to those described for S. pneumoniae. S. intermedius BA1 contains a coding sequence for ILY, a human-specific pore-forming toxin closely related to vaginolysin from Gardnerella vaginalis and inerolysin from Lactobacillus iners (10, 11). ILY is important in S. intermedius pathogenesis (12–14), and its production is regulated by sensation of nutrient availability via the catabolite control protein A (15), which is also encoded in the S. intermedius BA1 draft genome sequence. Capsular polysaccharide synthesis (cps) is involved in immune evasion by pathogenic streptococci (16), and the S. intermedius BA1 genome encodes proteins predicted to be involved in cps pathways. Natural competence for transformation is a driving force in streptococcal evolution (17, 18), and competence pathway components similar to those of S. pneumoniae were identified in the BA1 genome, as was a predicted competence-stimulating peptide precursor. Genes for sortases and their predicted substrates containing consensus LPXTG motifs, two-component signaling systems, adhesins, sialidases, quorum-sensing components, and a eukaryotic-like serine-threonine protein kinase/phosphatase pair (PrkC/PrpC) were also identified. No predicted siderophore genes were noted in the BA1 genome.

Nucleotide sequence accession numbers.

The sequence from this Whole Genome Shotgun project has been deposited in DDBJ/EMBL/GenBank under accession number ANFT00000000 (BioProject PRJNA178554, SubID SUB138006). The version described in this paper is the first version, ANFT01000000.
  18 in total

1.  Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess.

Authors:  H Nagamune; C Ohnishi; A Katsuura; K Fushitani; R A Whiley; A Tsuji; Y Matsuda
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

2.  Role of catabolite control protein A in the regulation of intermedilysin production by Streptococcus intermedius.

Authors:  Toshifumi Tomoyasu; Atsushi Tabata; Riki Hiroshima; Hidenori Imaki; Sachiko Masuda; Robert A Whiley; Joseph Aduse-Opoku; Ken Kikuchi; Keiichi Hiramatsu; Hideaki Nagamune
Journal:  Infect Immun       Date:  2010-07-12       Impact factor: 3.441

3.  Distribution of the intermedilysin gene among the anginosus group streptococci and correlation between intermedilysin production and deep-seated infection with Streptococcus intermedius.

Authors:  H Nagamune; R A Whiley; T Goto; Y Inai; T Maeda; J M Hardie; H Kourai
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

4.  Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus ("Streptococcus milleri group") are of different clinical importance and are not equally associated with abscess.

Authors:  J E Claridge; S Attorri; D M Musher; J Hebert; S Dunbar
Journal:  Clin Infect Dis       Date:  2001-04-20       Impact factor: 9.079

5.  Rapid identification of Streptococcus intermedius by PCR with the ily gene as a species marker gene.

Authors:  Takatsugu Goto; Hideaki Nagamune; Aiko Miyazaki; Yoshiaki Kawamura; Ooki Ohnishi; Kanako Hattori; Kazuto Ohkura; Kazuaki Miyamoto; Shigeru Akimoto; Takayuki Ezaki; Katsuhiko Hirota; Yoichiro Miyake; Takuya Maeda; Hiroki Kourai
Journal:  J Med Microbiol       Date:  2002-02       Impact factor: 2.472

6.  Intermedilysin is essential for the invasion of hepatoma HepG2 cells by Streptococcus intermedius.

Authors:  Akiko Sukeno; Hideaki Nagamune; Robert A Whiley; Syed I Jafar; Joseph Aduse-Opoku; Kazuto Ohkura; Takuya Maeda; Katsuhiko Hirota; Yoichiro Miyake; Hiroki Kourai
Journal:  Microbiol Immunol       Date:  2005       Impact factor: 1.955

7.  A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients.

Authors:  Christopher D Sibley; Michael D Parkins; Harvey R Rabin; Kangmin Duan; Jens C Norgaard; Michael G Surette
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

8.  Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections.

Authors:  R A Whiley; D Beighton; T G Winstanley; H Y Fraser; J M Hardie
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

9.  Hybrid error correction and de novo assembly of single-molecule sequencing reads.

Authors:  Sergey Koren; Michael C Schatz; Brian P Walenz; Jeffrey Martin; Jason T Howard; Ganeshkumar Ganapathy; Zhong Wang; David A Rasko; W Richard McCombie; Erich D Jarvis
Journal:  Nat Biotechnol       Date:  2012-07-01       Impact factor: 54.908

10.  Evolution of Streptococcus pneumoniae and its close commensal relatives.

Authors:  Mogens Kilian; Knud Poulsen; Trinelise Blomqvist; Leiv S Håvarstein; Malene Bek-Thomsen; Hervé Tettelin; Uffe B S Sørensen
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

View more
  2 in total

1.  Characterization of the Pathogenicity of Streptococcus intermedius TYG1620 Isolated from a Human Brain Abscess Based on the Complete Genome Sequence with Transcriptome Analysis and Transposon Mutagenesis in a Murine Subcutaneous Abscess Model.

Authors:  Noriko Hasegawa; Tsuyoshi Sekizuka; Yutaka Sugi; Nobuhiro Kawakami; Yumiko Ogasawara; Kengo Kato; Akifumi Yamashita; Fumihiko Takeuchi; Makoto Kuroda
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

Review 2.  From Normal Flora to Brain Abscesses: A Review of Streptococcus intermedius.

Authors:  Elio Issa; Tamara Salloum; Sima Tokajian
Journal:  Front Microbiol       Date:  2020-05-07       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.